News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
oryzon
ORYZON reports financial results and corporate update for quarter ended December 31, 2023
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies
Oryzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop…
Partners - Oryzon Genomics
Alira_foto_general
Why and how to involve rare disease patients in the evaluation process of a new health technology?
Healthcare · Rare diseases · Innovative drugs · Personalized medicine · Advanced therapies
Alira Health experts explain in an interview the importance of involving patients with rare…
experimento-cientifico-planta_144627-1310
European biotechnology proposes improvements to the European Biotechnology and Bio-manufacturing Initiative
Industrial biotechnology
EuropaBio, of which AseBio is a member, proposes five basic principles to achieve a competitive…
Marzo24_ASEBIO.jpg
BCN HEALTH publishes a study evaluating hospital incidence and medical costs associated with lupus in Spain
Healthcare · Rare diseases
BCN HEALTH has published the study "Incidence and medical costs of lupus in Spanish hospitals: a…
Partners - BCN Health
Premios_Periodismo_AseBio
#AseBioGallery | This is how the 'AseBio Journalism Awards' went
Communication · Talento · Corporate
The awards recognized the work of Belén Diego, collaborator for Diariofarma and correspondent for…
Nitrosaminas_B12
AMSbiopharma introduces an important advance for the analysis of nitrosamines in different active pharmaceutical ingredients of vitamin B12
Healthcare · Drug discovery
Nitrosamines represent a significant health risk, being potentially carcinogenic and a major…
Partners - AMSbiopharma
Carlos_Pérez_Sánchez_Cobiomic
#NewAseBioMember | “AseBio providing an unparalleled platform to collaborate with other companies in the sector”
Corporate
Meet Cobiomic Biosciences, our new member. We talked to its Carlos Pérez Sánchez,…
AseBio - COBIOMIC BIOSCIENCES S.L.
Foto de un trabajador de Almirall en el laboratorio
Almirall licenses an anti-IL-21 monoclonal antibody from Novo Nordisk to develop it as a first-in-class agent in dermatology
Healthcare · Access to innovation · Drug discovery · Innovative drugs
NN-8828 is a first-in-class monoclonal antibody in dermatology with high affinity for the cytokine…
Partners - Almirall
ProtoQSAR
The Spanish company ProtoQSAR participates in three new European projects!
EU projects
Partners - ProtoQSAR